Olfr701, a member of the olfactory receptor gene family, plays a pivotal role in the perception of odorant molecules in Mus musculus (house mouse). As a G-protein-coupled receptor (GPCR), Olfr701 is characterized by a 7-transmembrane domain structure, a common feature shared with various neurotransmitter and hormone receptors. This receptor is fundamental to the olfactory system's ability to detect and transduce odorant signals, ultimately triggering the perception of a specific smell. The olfactory receptor gene family is notably expansive, representing the largest group of genes in the genome. It's important to note that the nomenclature assigned to olfactory receptor genes and proteins in this organism is independent of other species. The function of Olfr701 lies in its role as a molecular sensor within the olfactory system. When odorant molecules interact with Olfr701, a complex cascade of events is initiated. These interactions lead to the activation of downstream signaling pathways, including the adenylate cyclase-cAMP-PKA pathway, MAPK pathway, and PI3K/Akt pathway, which collectively mediate the olfactory response. Olfr701's ability to recognize and bind to specific odorants is critical for initiating this neuronal response. The receptor's involvement in G-protein-mediated transduction of odorant signals highlights its significance in the process of olfaction.
Inhibition of Olfr701 can be achieved through various mechanisms, primarily involving the modulation of signaling pathways associated with olfaction. While direct inhibitors targeting Olfr701 itself may be limited, the complexity of olfactory signaling provides multiple points of intervention. These mechanisms include inhibiting specific enzymes such as phosphodiesterases (e.g., PDE4), which regulate cAMP levels, thereby indirectly affecting Olfr701 signal transduction. Additionally, targeting kinases such as MEK and JNK, which play roles in MAPK and related pathways, can indirectly influence Olfr701 function. Overall, Olfr701's function as an olfactory receptor is crucial for the perception of smells in house mice. While direct inhibitors of this receptor may be scarce, the intricate web of signaling pathways involved in olfaction offers potential avenues for modulation. Understanding the molecular basis of Olfr701's activation and inhibition contributes to unraveling the complexities of the olfactory system in mice and sheds light on the fascinating world of sensory perception.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis by interfering with ribosome function, indirectly affecting Olfr701 expression and signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram is a specific inhibitor of phosphodiesterase 4 (PDE4), reducing cAMP degradation and indirectly enhancing Olfr701 signal transduction. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels and subsequently enhancing Olfr701 activation and olfactory perception. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB-203580 is a potent inhibitor of p38 MAPK, a kinase involved in olfactory receptor regulation, indirectly impacting Olfr701 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K/Akt signaling, which plays a role in olfactory receptor function, indirectly influencing Olfr701 response to odorants. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a selective MEK inhibitor, affecting the MAPK pathway and indirectly modulating Olfr701 activation through downstream signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits PI3K, disrupting olfactory receptor-related pathways and indirectly affecting Olfr701 function and odor perception. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is a MEK1 and MEK2 inhibitor, interfering with MAPK signaling pathways, indirectly influencing Olfr701 response to odorant molecules. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $93.00 $356.00 | 13 | |
SQ22536 inhibits adenylate cyclase, reducing cAMP levels and indirectly suppressing Olfr701 activation and subsequent olfactory perception. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $107.00 $316.00 | 3 | |
Cilostazol is a phosphodiesterase 3 (PDE3) inhibitor, modulating cAMP levels and indirectly enhancing Olfr701 signal transduction. | ||||||